Sherwin-Williams (NYSE:SHW) PT Raised to $425.00

Sherwin-Williams (NYSE:SHW) had its price objective increased by equities research analysts at BMO Capital Markets from $400.00 to $425.00 in a note issued to investors on Monday, Benzinga reports. The brokerage presently has an “outperform” rating on the specialty chemicals company’s stock. BMO Capital Markets’ target price indicates a potential upside of 12.21% from the stock’s previous close.

A number of other equities analysts have also issued reports on the stock. Morgan Stanley increased their target price on shares of Sherwin-Williams from $338.00 to $375.00 and gave the company an “overweight” rating in a research report on Wednesday, July 24th. Robert W. Baird boosted their target price on Sherwin-Williams from $310.00 to $325.00 and gave the stock a “neutral” rating in a report on Wednesday, July 24th. UBS Group increased their price target on Sherwin-Williams from $375.00 to $412.00 and gave the company a “buy” rating in a research note on Friday, August 30th. Barclays raised their target price on Sherwin-Williams from $315.00 to $355.00 and gave the company an “equal weight” rating in a research note on Wednesday, July 24th. Finally, KeyCorp upped their price target on shares of Sherwin-Williams from $400.00 to $410.00 and gave the company an “overweight” rating in a report on Wednesday, July 24th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, Sherwin-Williams has an average rating of “Moderate Buy” and a consensus price target of $370.39.

Sherwin-Williams Stock Performance

SHW traded down $3.99 on Monday, hitting $378.74. 416,007 shares of the company’s stock were exchanged, compared to its average volume of 1,566,046. The company has a current ratio of 0.81, a quick ratio of 0.50 and a debt-to-equity ratio of 2.17. The stock has a fifty day moving average of $359.69 and a two-hundred day moving average of $329.68. Sherwin-Williams has a twelve month low of $232.06 and a twelve month high of $385.25. The firm has a market cap of $95.54 billion, a PE ratio of 40.34, a P/E/G ratio of 3.00 and a beta of 1.17.

Sherwin-Williams (NYSE:SHW) last issued its quarterly earnings data on Tuesday, July 23rd. The specialty chemicals company reported $3.70 EPS for the quarter, topping analysts’ consensus estimates of $3.51 by $0.19. The firm had revenue of $6.27 billion during the quarter, compared to the consensus estimate of $6.33 billion. Sherwin-Williams had a return on equity of 75.58% and a net margin of 10.92%. The firm’s revenue was up .5% on a year-over-year basis. During the same period in the prior year, the business earned $3.29 EPS. On average, research analysts anticipate that Sherwin-Williams will post 11.47 earnings per share for the current fiscal year.

Insider Transactions at Sherwin-Williams

In other news, CFO Allen J. Mistysyn sold 14,520 shares of the business’s stock in a transaction dated Friday, August 30th. The shares were sold at an average price of $366.83, for a total transaction of $5,326,371.60. Following the transaction, the chief financial officer now owns 63,520 shares in the company, valued at approximately $23,301,041.60. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.60% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of SHW. HHM Wealth Advisors LLC grew its stake in shares of Sherwin-Williams by 102.3% in the 2nd quarter. HHM Wealth Advisors LLC now owns 89 shares of the specialty chemicals company’s stock valued at $27,000 after purchasing an additional 45 shares during the period. Semmax Financial Advisors Inc. raised its stake in Sherwin-Williams by 136.4% during the second quarter. Semmax Financial Advisors Inc. now owns 104 shares of the specialty chemicals company’s stock worth $31,000 after acquiring an additional 60 shares in the last quarter. VitalStone Financial LLC lifted its holdings in shares of Sherwin-Williams by 233.3% during the second quarter. VitalStone Financial LLC now owns 110 shares of the specialty chemicals company’s stock valued at $33,000 after acquiring an additional 77 shares during the period. Anfield Capital Management LLC bought a new position in shares of Sherwin-Williams during the second quarter valued at $38,000. Finally, Northwest Investment Counselors LLC bought a new stake in shares of Sherwin-Williams in the 1st quarter worth about $47,000. 77.67% of the stock is currently owned by institutional investors and hedge funds.

Sherwin-Williams Company Profile

The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.